|
Secondary prevention
Citations 1-10 of 561 total displayed.
|
Most recent content
(3 Nov 2009):
|
- Interventional Cardiology
Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
- Konstantinos Spargias, Elias Adreanides, Eftihia Demerouti, Angeliki Gkouziouta, Athanassios Manginas, Gregory Pavlides, Vassilis Voudris, and Dennis V. Cokkinos
Circulation 2009;120:1793-1799; published online before print as doi:10.1161/CIRCULATIONAHA.109.863159
[Abstract]
[Full text]
- Articles
Secondary Prevention, the Interventional Way. Prophylactic Drug-Eluting Stents for Nonobstructive Saphenous Vein Graft Disease
- Sahil A. Parikh and Marco A. Costa
Circulation published November 2, 2009, doi:10.1161/CIRCULATIONAHA.109.903146
[Abstract]
|
Past content
(since Feb 1999):
|
- Correspondence
Response to Letter Regarding Article "Effects of the Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in the Raloxifene Use for the Heart Trial: Results of Subgroup Analyses by Age and Other Factors"
- Peter Collins, Lori Mosca, Mary Jane Geiger, Messan G. Amewou-Atisso, Mark B. Effron, Sherie Dowsett, Deborah Grady, Marcel Kornitzer, Elizabeth Barrett-Connor, and Nanette K. Wenger
Circulation 2009;120:e148, doi:10.1161/CIRCULATIONAHA.109.876920
[Full text]
- Epidemiology and Prevention
Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
- Eline S. van Hattum, Ale Algra, James A. Lawson, Bert C. Eikelboom, Frans L. Moll, and Marco J.D. Tangelder
Circulation 2009;120:1569-1576; published online before print as doi:10.1161/CIRCULATIONAHA.109.858365
[Abstract]
[Full text]
- Articles
Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
- Konstantinos Spargias, Elias Adreanides, Eftihia Demerouti, Angeliki Gkouziouta, Athanassios Manginas, Gregory Pavlides, Vassilis Voudris, and Dennis V. Cokkinos
Circulation published October 19, 2009, doi:10.1161/CIRCULATIONAHA.109.863159
[Abstract]
- Epidemiology and Prevention
Cardiovascular Benefit of Magnitude of Low-Density Lipoprotein Cholesterol Reduction: A Comparison of Subgroups by Age
- Catherine R. Rahilly-Tierney, Elizabeth V. Lawler, Richard E. Scranton, and J. Michael Gaziano
Circulation 2009;120:1491-1497; published online before print as doi:10.1161/CIRCULATIONAHA.108.846931
[Abstract]
[Full text]
- Epidemiology and Prevention
Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
- Paolo Verdecchia, Peter Sleight, Giuseppe Mancia, Robert Fagard, Bruno Trimarco, Roland E. Schmieder, Jae-Hyung Kim, Garry Jennings, Petr Jansky, Jyh-Hong Chen, Lisheng Liu, Peggy Gao, Jeffrey Probstfield, Koon Teo, Salim Yusuf for the ONTARGET/TRANSCEND Investigators
Circulation 2009;120:1380-1389; published online before print as doi:10.1161/CIRCULATIONAHA.109.865774
[Abstract]
[Full text]
- Articles
Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
- Eline S. van Hattum, Ale Algra, James A. Lawson, Bert C. Eikelboom, Frans L. Moll, and Marco J.D. Tangelder
Circulation published October 5, 2009, doi:10.1161/CIRCULATIONAHA.109.858365
[Abstract]
- Articles
Cardiovascular Benefit of Magnitude of Low-Density Lipoprotein Cholesterol Reduction. A Comparison of Subgroups by Age
- Catherine R. Rahilly-Tierney, Elizabeth V. Lawler, Richard E. Scranton, and J. Michael Gaziano
Circulation published September 28, 2009, doi:10.1161/CIRCULATIONAHA.108.846931
[Abstract]
- Articles
Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
- Paolo Verdecchia, Peter Sleight, Giuseppe Mancia, Robert Fagard, Bruno Trimarco, Roland E. Schmieder, Jae-Hyung Kim, Garry Jennings, Petr Jansky, Jyh-Hong Chen, Lisheng Liu, Peggy Gao, Jeffrey Probstfield, Koon Teo, Salim Yusuf for the ONTARGET/TRANSCEND Investigators
Circulation published September 21, 2009, doi:10.1161/CIRCULATIONAHA.109.865774
[Abstract]
|
|
